220 related articles for article (PubMed ID: 17043848)
1. Discrepancies between observed and predicted continuous venovenous hemofiltration removal of antimicrobial agents in critically ill patients and the effects on dosing.
Bouman CS; van Kan HJ; Koopmans RP; Korevaar JC; Schultz MJ; Vroom MB
Intensive Care Med; 2006 Dec; 32(12):2013-9. PubMed ID: 17043848
[TBL] [Abstract][Full Text] [Related]
2. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.
Joy MS; Matzke GR; Frye RF; Palevsky PM
Am J Kidney Dis; 1998 Jun; 31(6):1019-27. PubMed ID: 9631848
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration.
Radej J; Krouzecky A; Stehlik P; Sykora R; Chvojka J; Karvunidis T; Novak I; Matejovic M
Ther Drug Monit; 2011 Aug; 33(4):393-7. PubMed ID: 21654349
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of and maintenance dose recommendations for vancomycin in severe pneumonia patients undergoing continuous venovenous hemofiltration with the combination of predilution and postdilution.
Li Q; Liang F; Sang L; Li P; Lv B; Tan L; Liu X; Chen W
Eur J Clin Pharmacol; 2020 Feb; 76(2):211-217. PubMed ID: 31734748
[TBL] [Abstract][Full Text] [Related]
5. Improving antimicrobial dosing in critically ill patients receiving continuous venovenous hemofiltration and the effect of pharmacist dosing adjustment.
Jiang SP; Xu YY; Ping-Yang ; Wu WF; Zhang XG; Lu XY; Xiao YH; Liang WF; Chen J
Eur J Intern Med; 2014 Dec; 25(10):930-5. PubMed ID: 25153537
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of levofloxacin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients.
Guenter SG; Iven H; Boos C; Bruch HP; Muhl E
Pharmacotherapy; 2002 Feb; 22(2):175-83. PubMed ID: 11837556
[TBL] [Abstract][Full Text] [Related]
7. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
Boereboom FT; Ververs FF; Blankestijn PJ; Savelkoul TJ; van Dijk A
Intensive Care Med; 1999 Oct; 25(10):1100-4. PubMed ID: 10551965
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of cefpirome in critically ill patients with renal failure treated by continuous veno-venous hemofiltration.
Van der Werf TS; Fijen JW; Van de Merbel NC; Spanjersberg R; Möller AV; Ligtenberg JJ; Tulleken JE; Zijlstra JG; Stegeman CA
Intensive Care Med; 1999 Dec; 25(12):1427-31. PubMed ID: 10660852
[TBL] [Abstract][Full Text] [Related]
10. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration.
Heering P; Morgera S; Schmitz FJ; Schmitz G; Willers R; Schultheiss HP; Strauer BE; Grabensee B
Intensive Care Med; 1997 Mar; 23(3):288-96. PubMed ID: 9083231
[TBL] [Abstract][Full Text] [Related]
11. Phenytoin removal by continuous venovenous hemofiltration.
Oltrogge KM; Peppard WJ; Saleh M; Regner KR; Herrmann DJ
Ann Pharmacother; 2013 Sep; 47(9):1218-22. PubMed ID: 24259740
[TBL] [Abstract][Full Text] [Related]
12. [The effects of dialysate and ultrafiltration flow rate on solute clearance during continuous renal replacement therapy].
Gong D; Ji D; Xie H; Xu B; Liu Y; Li L
Zhonghua Nei Ke Za Zhi; 2001 Mar; 40(3):183-6. PubMed ID: 11798577
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of antimicrobial agents in anuric patients during continuous venovenous haemofiltration.
Joos B; Schmidli M; Keusch G
Nephrol Dial Transplant; 1996 Aug; 11(8):1582-5. PubMed ID: 8856215
[TBL] [Abstract][Full Text] [Related]
14. Dosing of antimicrobial agents in critically-ill patients with acute kindey injury and continuous venvenous haemofiltration.
Bouman CS
Acta Clin Belg; 2007; 62 Suppl 2():365-70. PubMed ID: 18284001
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of lorazepam and midazolam and their metabolites in intensive care patients on continuous venovenous hemofiltration.
Swart EL; de Jongh J; Zuideveld KP; Danhof M; Thijs LG; Strack van Schijndel RJ
Am J Kidney Dis; 2005 Feb; 45(2):360-71. PubMed ID: 15685515
[TBL] [Abstract][Full Text] [Related]
16. Gentamicin pharmacokinetics during continuous venovenous hemofiltration in critically ill septic patients.
Petejova N; Zahalkova J; Duricova J; Kacirova I; Brozmanova H; Urbanek K; Grundmann M; Martinek A
J Chemother; 2012 Apr; 24(2):107-12. PubMed ID: 22546767
[TBL] [Abstract][Full Text] [Related]
17. Population Pharmacokinetics of Cefuroxime in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration With Regional Citrate Anticoagulation and a Phosphate-Containing Replacement Fluid.
Janssen PK; Foudraine NA; Burgers DM; Neef K; le Noble JL
Ther Drug Monit; 2016 Dec; 38(6):699-705. PubMed ID: 27494946
[TBL] [Abstract][Full Text] [Related]
18. Multiple-dose pharmacokinetics of linezolid during continuous venovenous haemofiltration.
Meyer B; Kornek GV; Nikfardjam M; Karth GD; Heinz G; Locker GJ; Jaeger W; Thalhammer F
J Antimicrob Chemother; 2005 Jul; 56(1):172-9. PubMed ID: 15905303
[TBL] [Abstract][Full Text] [Related]
19. Continuous veno-venous hemofiltration in Bhumibol Adulyadej Hospital.
Chuasuwan A; Gojaseni P; Chittinandana A
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S86-97. PubMed ID: 17044459
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of Imipenem/Cilastatin Burn Intensive Care Unit Patients Undergoing High-Dose Continuous Venovenous Hemofiltration.
Boucher BA; Hudson JQ; Hill DM; Swanson JM; Wood GC; Laizure SC; Arnold-Ross A; Hu ZY; Hickerson WL
Pharmacotherapy; 2016 Dec; 36(12):1229-1237. PubMed ID: 27862103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
